Publications by authors named "Luis Palomero"

19Publications

Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment.

Eur Urol 2020 Nov 2. Epub 2020 Nov 2.

Program of Molecular Mechanisms and Experimental Therapeutics in Oncology, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, Gran Via de L'Hospitalet, Barcelona, Spain; Program Against Cancer Therapeutics Resistance (ProCURE), Catalan Institute of Oncology, Gran Via de L'Hospitalet, Barcelona, Spain. Electronic address:

View Article and Find Full Text PDF
November 2020

NEK10 tyrosine phosphorylates p53 and controls its transcriptional activity.

Oncogene 2020 07 19;39(30):5252-5266. Epub 2020 Jun 19.

Department of Medical Biophysics, Princess Margaret Cancer Research Tower, University of Toronto, Toronto, ON, M5G 1L7, Canada.

View Article and Find Full Text PDF
July 2020

EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell Carcinoma.

Cancers (Basel) 2020 Jan 28;12(2). Epub 2020 Jan 28.

ProCURE, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona 08908, Catalonia, Spain.

View Article and Find Full Text PDF
January 2020

Antitumor Effects of Anti-Semaphorin 4D Antibody Unravel a Novel Proinvasive Mechanism of Vascular-Targeting Agents.

Cancer Res 2019 Oct 25;79(20):5328-5341. Epub 2019 Jun 25.

Tumor Angiogenesis Group, ProCURE Research Program, Catalan Institute of Oncology, OncoBell Program, IDIBELL, Barcelona, Spain.

View Article and Find Full Text PDF
October 2019

NSD2 is a conserved driver of metastatic prostate cancer progression.

Nat Commun 2018 12 5;9(1):5201. Epub 2018 Dec 5.

Department of Urology, Columbia University Irving Medical Center, 160 Fort Washington Ave, New York, NY, 10032, USA.

View Article and Find Full Text PDF
December 2018

Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance.

Dis Model Mech 2018 05 18;11(5). Epub 2018 May 18.

Breast Cancer and Systems Biology Laboratory, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona 08908, Catalonia, Spain

View Article and Find Full Text PDF
May 2018